1,837 reports of this reaction
2.1% of all DIVALPROEX SODIUM reports
#8 most reported adverse reaction
SOMNOLENCE is the #8 most commonly reported adverse reaction for DIVALPROEX SODIUM, manufactured by AbbVie Inc.. There are 1,837 FDA adverse event reports linking DIVALPROEX SODIUM to SOMNOLENCE. This represents approximately 2.1% of all 87,440 adverse event reports for this drug.
Patients taking DIVALPROEX SODIUM who experience somnolence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SOMNOLENCE is a less commonly reported adverse event for DIVALPROEX SODIUM, but still significant enough to appear in the safety profile.
In addition to somnolence, the following adverse reactions have been reported for DIVALPROEX SODIUM:
The following drugs have also been linked to somnolence in FDA adverse event reports:
SOMNOLENCE has been reported as an adverse event in 1,837 FDA reports for DIVALPROEX SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
SOMNOLENCE accounts for approximately 2.1% of all adverse event reports for DIVALPROEX SODIUM, making it a notable side effect.
If you experience somnolence while taking DIVALPROEX SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.